Addressing gaps in AMR awareness in the public: an evidence-based policy brief to guide school curriculum review in Uganda.
AMR
antimicrobial resistance
curriculum review
policy brief
public awareness
school education
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
05
09
2023
accepted:
30
10
2023
medline:
11
12
2023
pubmed:
11
12
2023
entrez:
11
12
2023
Statut:
epublish
Résumé
The government of Uganda, through its Ministry of Health, previously adopted curriculum review as a mechanism to respond to public health threats such as HIV/AIDS and include content in primary and secondary schools. This approach contributes to raising public awareness, a key strategy recommended by the World Health Organization to support the global response to the threat of antimicrobial resistance (AMR). This policy brief, developed for policymakers related to school curricula, aims to advocate for and support integration of AMR content in Uganda's primary and secondary level school curricula. The policy brief supports efforts by the multisectoral National AMR Subcommittee to create awareness on this issue as part of its role in facilitating the operationalization of Uganda's National Action Plan on AMR.
Identifiants
pubmed: 38074735
doi: 10.3389/fpubh.2023.1287523
pmc: PMC10707988
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1287523Informations de copyright
Copyright © 2023 Waswa, Kiggundu, Joshi, Mpagi, Kasujja, Murungi, Kajumbula, Were, Schwarz, Lwere and Konduri.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Trop Med Int Health. 2002 Dec;7(12):1031-41
pubmed: 12460394
Antimicrob Resist Infect Control. 2022 Nov 25;11(1):145
pubmed: 36434685
J Pharm Policy Pract. 2021 Aug 20;14(1):69
pubmed: 34416911
Porto Biomed J. 2017 Sep-Oct;2(5):157-160
pubmed: 32258612
Children (Basel). 2022 Oct 20;9(10):
pubmed: 36291523
J Sch Health. 1990 Aug;60(6):262-5
pubmed: 2232729
PeerJ Comput Sci. 2022 May 30;8:e967
pubmed: 35721401
PLoS One. 2020 Aug 10;15(8):e0237085
pubmed: 32776958
Int J Microbiol. 2017;2017:3183076
pubmed: 28270849
Lancet Glob Health. 2023 Jan;11(1):e59-e68
pubmed: 36521953
Schriftenr Ver Wasser Boden Lufthyg. 2000;105:377-81
pubmed: 10842841
Clin Microbiol Infect. 2022 Mar;28(3):345-354
pubmed: 34768017
PLoS One. 2022 Dec 30;17(12):e0279342
pubmed: 36584014
J Clin Med. 2019 Jan 12;8(1):
pubmed: 30642058
J Infect Prev. 2019 Nov;20(6):281-288
pubmed: 31762790
PLoS One. 2022 Feb 3;17(2):e0262993
pubmed: 35113932
Infect Drug Resist. 2021 Jun 10;14:2155-2164
pubmed: 34140783
Afr J AIDS Res. 2018 Jul;17(2):153-162
pubmed: 30003847
J Neurosci. 2016 Aug 3;36(31):8103-11
pubmed: 27488631
Scand J Public Health. 2009 Jun;37 Suppl 2:55-64
pubmed: 19493982
Antibiotics (Basel). 2021 Dec 11;10(12):
pubmed: 34943732
BMC Public Health. 2021 Nov 29;21(1):2188
pubmed: 34844593
JAC Antimicrob Resist. 2019 Nov 13;1(3):dlz073
pubmed: 34222946
PLoS One. 2020 Oct 29;15(10):e0240471
pubmed: 33119647
Antibiotics (Basel). 2022 Feb 04;11(2):
pubmed: 35203802
JAC Antimicrob Resist. 2020 Oct 16;2(4):dlaa082
pubmed: 34223037
Acc Chem Res. 2019 Apr 16;52(4):916-924
pubmed: 30848890
Antimicrob Resist Infect Control. 2020 May 20;9(1):72
pubmed: 32434552
One Health Outlook. 2023 Apr 14;5(1):7
pubmed: 37055845
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
BMC Infect Dis. 2015 Jul 14;15:268
pubmed: 26170127
Glob Public Health. 2022 Nov;17(11):2647-2664
pubmed: 34882505
Infect Drug Resist. 2023 Apr 13;16:2179-2190
pubmed: 37077250
SAHARA J. 2015;12:30-8
pubmed: 26365812